Posted on September 15, 2017 in: Member News
After researching and discussing the issue, the Task Force proposed a position of studied neutrality on whether pharmacists should participate in medical aid in dying. They defined studied neutrality as “the careful or premeditated practice of being neutral in a dispute … to foster a respectful culture among people of diverse views and to guide action that does not afford material advantage to a [particular] group.”1 The Task Force cited a desire to promote patient autonomy and access to care and to protect pharmacists’ professional integrity and comity as the rationale for this stance. The recommended policy also reaffirmed that a pharmacist’s decision to participate is one of individual conscience, and that participation or refusal to participate should not result in retribution, which was similar to the existing ASHP policy. While some delegates supported an amendment for ASHP to take an opposition stance, in the end the proposed policy passed as written, with the new ASHP Policy 1704 superseding ASHP Policy 9915.
I again encourage you to review all the new policies on the ASHP website, since this summary only scratches the surface of this year’s House of Delegates activities. On behalf of my fellow delegates, thank you for allowing us to serve as your delegates this year!